D-0490-2019 Class III Terminated
FDA drug recall D-0490-2019 was initiated by Valeant Pharmaceuticals North America LLC on Jan 30, 2019 and is designated Class III. Reason for recall: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points. The recall status is terminated (terminated Jul 8, 2020). Affected quantity: 22 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 20, 2019
- Initiation Date
- Jan 30, 2019
- Termination Date
- Jul 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22 bottles
Product description
Cardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187-0798-30); and b) 90-count bottles (NDC 0187-0798-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.
Reason for recall
Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lots: a)18J020P, Exp 08/2020; b) 18J034P, Exp 08/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0490-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026